Contraline's Unattributed Round

Contraline raised a round of funding on June 13, 2016.

Contraline is a biotechnology company developing a long-lasting, nonhormonal, and reversible male contraceptive. Contraline's first product, Echo-V, is a polymer gel that is implanted nonsurgically vi…

Articles about Contraline's Unattributed Round: